Evaluation of the Clinical Performance of Reinforced Glass Ionomer Restorations
NCT ID: NCT04288791
Last Updated: 2020-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-06-01
2019-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Evaluation of a Glass Ionomer Cement (GIC) Based Restorative System Versus Bulk Filled Resin-based Composite
NCT02479711
Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients
NCT04298151
Clinical Performance of a Glass-ionomer Restorative System: A 6-year Evaluation
NCT02888912
Clinical Performance and Wear Resistance of Two Nano Ceramic Resin Composite in Class I Cavities
NCT04738604
Glass Hybrid Versus Composite Restorations of Non-carious Cervical Lesions
NCT02631161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Equia Forte Fil
Equia Forte Fil
Glass hybrid innovation achieved through the introduction of ultrafine, highly reactive glass particles dispersed with conventional GI. The restoration is coated with Equia Forte coat which incorporates multi-functional monomer producing a tougher resin matrix. This system is designed as alternative of amalgam in posterior teeth.
Zirconomer Improved
Zirconia reinforced GI, Glass Polyalkenoate restoration; it is designed to exhibit high strength where the glass component of this GI undergoes finely controlled micronization to achieve optimum particle size and characteristics .
Zirconomer Improved
Equia Forte Fil
Glass hybrid innovation achieved through the introduction of ultrafine, highly reactive glass particles dispersed with conventional GI. The restoration is coated with Equia Forte coat which incorporates multi-functional monomer producing a tougher resin matrix. This system is designed as alternative of amalgam in posterior teeth.
Zirconomer Improved
Zirconia reinforced GI, Glass Polyalkenoate restoration; it is designed to exhibit high strength where the glass component of this GI undergoes finely controlled micronization to achieve optimum particle size and characteristics .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Equia Forte Fil
Glass hybrid innovation achieved through the introduction of ultrafine, highly reactive glass particles dispersed with conventional GI. The restoration is coated with Equia Forte coat which incorporates multi-functional monomer producing a tougher resin matrix. This system is designed as alternative of amalgam in posterior teeth.
Zirconomer Improved
Zirconia reinforced GI, Glass Polyalkenoate restoration; it is designed to exhibit high strength where the glass component of this GI undergoes finely controlled micronization to achieve optimum particle size and characteristics .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Absence of pain from the tooth to be restored.
* Absence of any active periodontal and pulpal diseases from the tooth to be restored.
* Medium-sized (buccolingually and mesio-distally) occlusal carious lesions extending into dentin.
Exclusion Criteria
* Patients with bruxism.
* Defective restorations adjacent or opposing to the tooth.
* Abutment teeth used for fixed or removable prosthesis.
* Patients who refused to sign the consent form.
* Inability to return to recall appointments
20 Years
47 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nessma Mohamed Mahmoud Sedky
Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al-Azhar University, Faculty of Dentistry For Girls
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC16-033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.